Adc Therapeutics Sa (ADCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2023 | 09-2023 | 06-2023 | 03-2023 | 12-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -240,053 | -155,022 | -108,296 | -59,374 | -157,128 |
| Depreciation Amortization | 3,267 | 2,420 | 1,535 | 723 | 2,388 |
| Income taxes - deferred | 37,104 | -5,750 | -5,172 | -69 | -1,621 |
| Accounts receivable | 47,789 | 51,787 | 49,089 | 48,901 | -42,753 |
| Accounts payable and accrued liabilities | 3,173 | -3,398 | -687 | -3,663 | 310 |
| Other Working Capital | 45,987 | 37,469 | 37,932 | 32,911 | -48,725 |
| Other Operating Activity | -15,953 | -14,559 | -24,781 | -34,821 | 109,218 |
| Operating Cash Flow | $-118,686 | $-87,053 | $-50,380 | $-15,392 | $-138,311 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -3,216 | -2,889 | -2,228 | -1,016 | -687 |
| Investing Cash Flow | $-3,216 | $-2,889 | $-2,228 | $-1,016 | $-687 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 115,597 |
| Debt Repayment | N/A | N/A | N/A | N/A | -118,304 |
| Common Stock Issued | 773 | 774 | N/A | 425 | 6,130 |
| Other Financing Activity | 73,102 | 73,102 | 73,527 | 0 | -4,320 |
| Financing Cash Flow | $73,875 | $73,876 | $73,527 | $425 | $-897 |
| Exchange Rate Effect | 184 | 32 | 150 | 89 | -208 |
| Beginning Cash Position | 326,441 | 326,441 | 326,441 | 326,441 | 466,544 |
| End Cash Position | 278,598 | 310,407 | 347,510 | 310,547 | 326,441 |
| Net Cash Flow | $-47,843 | $-16,034 | $21,069 | $-15,894 | $-140,103 |
| Free Cash Flow | |||||
| Operating Cash Flow | -118,686 | -87,053 | -50,380 | -15,392 | -138,311 |
| Capital Expenditure | -3,216 | -2,889 | -2,228 | -1,016 | -687 |
| Free Cash Flow | -121,902 | -89,942 | -52,608 | -16,408 | -138,998 |